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a  b  s  t  r  a  c  t
2-Aminothiazoline-4-carboxylic  acid  (ATCA)  was  intravenously  injected  to  rats  in  order  to investigate
its  plasma  distribution.  ATCA  was  extracted  from  plasma  samples  by solid  phase  extraction  (SPE)  and
molecularly  imprinted  polymer  stir  bar  sorption  extraction  (MIP-SBSE).  Detection  and  quantification  of
ATCA  were  achieved  by using  liquid  chromatography–tandem  mass  spectrometry  (LC–MS/MS).  It was
found  that  the  intravenously  injected  ATCA  concentration  quickly  decreased  to half  within  2.5  h  in the  rat
system.  However,  after  2.5  h,  the concentration  of ATCA  in  plasma  stayed  constant  at least  5  folds  above
the endogenous  ATCA  level  for  more  then  48 h. This  finding  can  be used  for  evaluating  ATCA’s diagnostic
and  forensic  value  as a  biomarker  for cyanide  exposure.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Formation of thiocyanate (SCN−) in the presence of the sulfur-
transferase, also known as rhodanese, is a well-known cyanide
metabolic pathway and has been well studied and published
[1–5]. Wood and Cooley reported in the early fifties that 2-
aminothiazoline-4-carboxylic acid (ATCA) is formed in the body
from cystine and cyanide via beta-thiocyano-alanine [6]. The roles
of any enzymes in ATCA formation in the body has not been ruled
out. Under normal condition (pH 7.4), 56% of cyanide is trans-
formed to SCN−, and just 23% is converted to ATCA [7]. Cyanide
also reacts with certain disulfides within human serum albumin
(HSA) via a stable cysteine-SCN adduct [8,9]. Although formation
of SCN− is regarded as the main pathway of cyanide detoxifica-
tion, the alternative biotransformation pathway of ATCA formation
becomes more important under some conditions, such as chronic
cyanide exposure when cyanide depletes sulfur donors preventing
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the formation of SCN− [10,11], and during metabolic acidosis (the
optimal pH for rhodanese is 8.5).
In order to study the in vivo behavior of ATCA, it was necessary
to develop suitable and sensitive analytical methods to detect it
in biological samples. Recent analytical method developments for
ATCA determination made it possible to establish the endogenous
level of ATCA in the studied biological matrices and detect cyanide
exposure [12]. Baskin et al. reported a spectrophotometric method,
and indicated a demand for more sensitive and specific analytical
techniques for ATCA determination [13,14]. Logue et al. determined
ATCA in human urine and plasma for smokers and non-smokers
using a GC–MS [15,16]. The methods were sensitive and required
a derivatization step with MSTFA ((N-methy-N-(trimethylsilyl) tri-
fluoroacetamide) in hexane. Jackson et al. reported a new, simple
analytical method without derivatization for analyzing ATCA in
biological samples by employing molecularly imprinted polymer
stir bar sorption extraction (MIP-SBSE) and electrospray ionization
tandem mass spectroscopy [17].
For this present study, ATCA samples were analyzed by a mod-
ified LC–MS/MS analytical method with a solid phase extraction
(SPE) sample preparation, compared to the MIP-SBSE extraction
technique. To explore the potential that ATCA might serve as a diag-
nostic biomarker, it is important to carry out more detailed studies
of its in vivo behavior and stability. The purpose of this study was to
1570-0232/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
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measure ATCA plasma distribution after direct intravenous injec-
tion of ATCA into rat, and to examine its persistence in the plasma by
utilizing our latest LC–MS/MS analytical technique with SPE sample
preparation.
2. Materials and methods
2.1. Chemicals and samples
All solvents used in this study were HPLC grade. Trifluoroacetic
acid (TFA) was purchased from EMD  Chemicals (Gibbstown, NJ,
USA) and used to prepare 0.5% (v/v) TFA in methanol as the
mobile phase. 2-Aminothiazoline-4-carboxylic acid (ATCA) was
obtained from Chem-Impex International (Wood Dale, IL, USA).
2-Aminothiazole-4-carboxylic acid (ATZA) was obtained from Syn-
thonix (Wake Forest, NC, USA) and used as an internal standard
for calibration. Potassium cyanide (KCN) was purchased from
Sigma–Aldrich (St. Louis, MO,  USA). For in vivo study, serial
dilutions were used to produce aqueous KCN solutions of sys-
tematically decreasing concentration. Oasis® MCX  (mixed-mode
cation exchange) cartridges were obtained from Waters Corpora-
tion (Milford, MA,  USA). Molecularly imprinted polymer stir bar
was prepared in house [17].
2.2. Animals
250–300 g male rats (CD® IGS) with catheters implanted were
purchased from Charles River (Charles River Breeding Laborato-
ries, Inc., Wilmington, MA). The experimental animals were housed
in room temperature and light controlled rooms (22 ± 2 ◦C, 12-
h light/dark cycle). They were furnished with water and Teklad
Rodent Diet (W)  8604 (Teklad HSD, Inc., WI,  USA) ad libitum.
All animal procedures were conducted in accordance with the
guidelines in The Guide for the Care and Use of Laboratory Ani-
mals (National Academic Press, 1996). The research facility was
accredited by AAALAC (American Association for the Assessment
and Accreditation of Laboratory Animal Care, International) and
this animal study was approved by the IACUC (Institutional Ani-
mal  Care and Use Committee) at Sam Houston State University
(SHSU).
2.3. Animal treatments and sample plasma preparation
To measure the persistence of ATCA in plasma 100 mg/kg-body-
weight of ATCA standard was injected by tail vein in a group of 3
rats. Blood samples were taken at the following time intervals: 5, 15,
30, 60 min, and 2, 4, 6, 12, 24, 48 h after ATCA injection. The average
volume of blood obtained was 0.25 mL,  and the blood was placed
into Eppendorf tubes with 40 L of 10 mg/mL  of heparin in water.
With this design of experiment, 2.5 mL  of blood (10 × 0.25 mL) was
taken from each rat in 2 days. Since we did not want to exceed
the limitation of the blood amounts what can be taken from each
animal, more data points could only be obtained if we  setup a
new group of animals with other time intervals. For the purpose
of determining ATCA persistence in the circulation, we thought
that sampling for two days should be enough. The Eppendorf tubes
were vortexed, then centrifuged at 13,000 rpm for 5 min. Plasma
was then collected. ATCA concentrations in plasma were measured
by LC–MS/MS after SPE. Note that if sample is gelled and it is not
possible to pipette, use 95 mg  of sample and add 600 L of 1% HCl
in acetone in a 15 mL  polypropylene conical tube. Cap the tube and
vortex it for 2 min  and centrifuge the tube for 4 min  at 10,000 rpm.
Then, take 350 L of supernatant liquid and add 3.15 mL  of 0.1 M
HCl for SPE. For the purpose of determining ATCA persistence in
the circulation, we  thought that sampling for two days should be
enough.
2.4. SPE extraction
Cation exchange solid-phase extraction (SPE) columns and indi-
vidual pre-treatment steps for the extraction and analysis of ATCA
from biological samples have been reported [18,19].  In our work,
the MCX  SPE cartridges were activated by adding 1 mL  of methanol
followed by 1 mL  DI water. Then the plasma samples were loaded
into the cartridges. The cartridges were washed with 1 mL of 0.1 M
HCl followed by 1 mL  of methanol. After new test tubes were placed
into SPE manifold, the ATCA was eluted with 1 mL  of NH4OH. After
all solution went through, the vacuum was  turned on for 1 min to
drain through the eluate completely. The samples were dried with
an air stream then 200 L of mobile phase was  added to reconsti-
tute the extracts waiting for LC–MS/MS analysis.
2.5. Molecularly imprinted polymer stir bar extraction
The original extraction method was published by Jackson et al.
[17]. Briefly, the glass stir bar with the screw in place was added
to a small vial with 0.5% acetic acid in methanol and sonicated
for 5 min  to clean the stir bar. In a 8 mL  vial with the molecularly
imprinted polymer stir bar (MIP-SB), 1 mL  of 1% aqueous acetic acid
and 200 L plasma sample was  added. The 8 mL  vial on positioned
on the stir plate, set at 700 rpms, and allow sample to run for 30 min
to extract the ATCA from the solution. After 30 min  of extraction,
the magnetic rod was used to put the MIP-SB into a sample vial
with 200 L of mobile phase. The solution and the stir bar were
sonicated for 5 min  to desorb ATCA. After the 5 min the MIP-SB was
removed from the sample solution. The sample solution was  ana-
lyzed by LC–MS/MS and the MIP-SB was washed with 1 mL 0.5%
acetic acid in methanol for regeneration.
2.6. ATCA measurement
In this work, detection and quantification of ATCA was
accomplished by using a LC–MS/MS. Sample preparation and
instrumentation details of ESI/MS/MS for the detection of ATCA
can be found in our previous report [17]. Briefly, a Shimadzu liquid
chromatograph (LC-20AT, Shimadzu, Columbia, MD)  coupled to a
tandem mass spectrometer (API 3200 ESI/MS/MS system, Applied
Biosystems, Foster City, CA) was  employed for the LC–MS/MS
separation, detection and quantification of ATCA. A Luna CN col-
umn  (3 m, 100 × 2 mm;  Phenomenex; Torrance, CA, USA) was
used for the separation. A 5 L aliquot of sample after SPE was
injected to the LC–MS/MS by an auto-sampler, and eluted isocrat-
ically at a 0.5 mL/min flow rate. Electrospray ionization (ESI) was
used at the LC and MS/MS  interface. Transition ions of ATCA (m/z
147 + → 101+) and ATZA (m/z 145 + → 127+) were monitored under
multiple reaction monitoring (MRM)  mode. The conditions of ESI
were as follows: ionspray voltage: +5500 V, temperature: 450 ◦C,
curtain gas 50 psi, gas 1: 70 psi, gas 2: 20 psi. The MS/MS  parameters
were as follows: collision gas (CAD): 6 psi, collision cell entrance
potential: 14 V, and the collision cell exit potential: 4 V.
3. Results and discussion
3.1. Extraction method comparison
Two extraction techniques, solid phase extraction (SPE) cation
exchange and molecular imprinted polymer stir bar (MIP-SB),
were compared for ATCA extraction. SPE and MIP-SBSE both have
strengths and weaknesses. Using SPE, as shown in Fig. 1, the
results show that there are some interferences near the ATCA
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Fig. 1. LC–MS/MS chromatogram for ATCA with SPE extraction (the spiked level of
ATCA was  500 ng/mL).
peak due to the biological nature of the extraction. As seen in
Fig. 2, when MIP-SBSE was used, ATCA was the only peak appeared
in the chromatogram. It suggested MIP-SBSE was more selec-
tive. Unfortunately, MIP-SB could not offer enough capacity and
suffered from low recoveries when compared to regular SPE tech-
nique [17]. Moreover, the SPE–LC–MS/MS offered a good precision
and reproducibility. With the use of internal standard calibra-
tion, calibration curves yielded an average calibration equation
y = (0.018 ± 0.00007) × (n=4, RSD of slope = 4%, between days). For a
250 ng/mL sample, %RSD = 5.9% (n = 3) was obtained in a within day
analysis. Limit of detection (LOD) and limit of quantitation (LOQ) of
the SPE–LC–MS/MS method were 12 ng/mL and 15 ng/mL, respec-
tively. More details of the traditional validation parameters of the
SPE–LC–MS/MS method can be found from our previous report [20].
Therefore, SPE was selected for this study as a better extraction
method for plasma samples.
3.2. ATCA persistence
The persistence of ATCA is an important factor to determine
whether ATCA is a good diagnostic biomarker for cyanide poi-
soning. A long-lasting biomarker will also offer a better forensic
value in most of the criminal cases. In other words, if ATCA is
quickly eliminated from the biological system, it will not be a
good biomarker for forensic applications. In this study, ATCA was
injected to rats in order to see how ATCA concentration changed
in plasma samples after intravenous administration. As shown in
Fig. 3 (when 100 mg  ATCA/kg-body-weight injected), ATCA concen-
tration in plasma showed an initial rapid decrease with a 1/e  time
constant of 1.26 min  that we postulate corresponds to an organ
equilibration time. After this equilibration, ATCA concentrations
Fig. 2. LC–MS/MS chromatogram for ATCA with MIP-SBSE extraction (the spiked
level of ATCA was 500 ng/mL).
Fig. 3. ATCA concentrations in the plasma samples after intravenously injection of
ATCA (100 mg/kg-body-weight) in rats.
stabilize. Specifically, the stabilized ATCA concentration from 2 h to
48 h was  718 ± 78 (n = 6) ng/mL, which is significantly higher then
the endogenous level, 141 ± 26 (n = 3) ng/mL. This result demon-
strated that ATCA is stable in plasma and metabolically inert for at
least 48 h.
3.3. ATCA as a biomarker for CN exposure
Increased concentration of ATCA in human urine were observed
in urine [15] and plasma were observed when comparing smok-
ers to non smokers, which suggested that ATCA could be a good
biomarker for CN exposure [16]. It is obviously true that if ATCA
is quickly eliminated from the biological system, it will not be a
good biomarker for cyanide poisoning. The objective of this study
was setup for determining the persistence of ATCA in blood, after
injecting ATCA directly to the blood stream. The result of this study
showed that after an initial loss of ATCA, the remaining amounts of
ATCA in blood (600 ng/mL) stayed stable over 48 h. The remaining
amount of ATCA was  significantly (5×)  higher than the endogenous
ATCA level without CN exposure. This 48 h persistence in the cir-
culation declares ATCA as a biologically stable CN antidote, with a
potential importance to be considered as a CN biomarker. Unfor-
tunately, it has been shown recently that ATCA concentrations in
plasma samples were not increased when rats were exposed to
a sublethal dose of KCN [20]. Since ATCA blood concentration did
not increase after sublethal dose of KCN exposure, it suggested that
blood is not a good matrix to detect ATCA as a diagnostic marker for
CN exposure. However, ATCA concentration levels in organs, such
as liver, were all increased after injection of KCN. These findings
were suggesting that ATCA could serve as a biomarker for foren-
sic purposes. It is also known that different species has different
metabolizing enzyme systems [1,21,22], what can drive to contra-
dictions in results with metabolites. The role of ATCA as a biomarker
for CN exposure should become clear as future investigations of the
behavior of ATCA are completed.
4. Conclusion
Our studies focused on determining plasma distribution of ATCA
after administering intravenously to rat. From the results, the initial
rapid loss of ATCA in plasma is estimated as the equilibrium with
the organs in the body. After this equilibrium time ATCA showed
a stable persistence over 48 h what confirms that it is a metaboli-
cally stable CN antidote. As reported by Petrikovics et al. [20], ATCA
has been proved as a forensic diagnostic biomarker, what enhances
the forensic importance of ATCA as a chemically stable biomarker.
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New studies with prolonged time intervals are needed to determine
the actual half-life for ATCA in the circulation following AAALAC
guidelines for the practical animal handling issues, such as the
limitations of the volume of blood drawn vs. body weight.
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